PD-1 can promote the development, immunity evasion, and prognosis of several kinds of solid tumor, such as NSCLC, melanoma, breast cancer (BC), and renal cell carcinoma (RCC) [34]. This evidence concerns the gene PDCD1 and breast cancer.